RAP will receive around $1.6M of R&D rebate in Q4 (like last year) so very doubtful they can't repay this $600K bridging loan. I think RAP just need the short term funds for this quarter, however, the important part of this announcement is Pfizer isn't going to increase their bid without others bids occurring.
RAP Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
HotCopper & The Market Online will be live From the Floor at the Mining News Select Conference and we want to bring the voice of our online audience to the show with us.
